Senior Researcher Dr. Giedrė Tamulaitienė and colleagues from Vilnius University Life Sciences Center (VU LSC), in collaboration with the researchers from Weizmann Institute of Sciences (Israel), revealed an activation mechanism of the Thoeris antiviral defense system effector.